Washington: U.S. President Donald Trump has once again turned his attention to the pharmaceutical sector—an industry he regards as central to Ireland’s economy—by signalling that he is still considering imposing tariffs on pharmaceutical imports.
Speaking recently, President Trump indicated that while a final decision has yet to be made, a 25% tariff on pharmaceutical products is under active consideration. He compared the potential levy to existing tariffs on steel and aluminium within the automotive sector. Trump specifically named Ireland and China as key producers of pharmaceutical goods, asserting that the U.S. needs to re-establish domestic production in this critical industry.
“All the drug companies are in Ireland. They don’t manufacture here. All we can do is impose tariffs—and that’s what we’ll do,” Trump said. He has previously expressed frustration with the number of U.S. pharmaceutical companies that have based their operations in Ireland due to favourable tax and regulatory environments.
The president also claimed that U.S. companies have invested trillions of dollars domestically since the introduction of earlier tariffs, though he did not provide specific data to support the assertion.
Ireland Braces for Impact
Responding to Trump’s latest remarks, Ireland’s Minister for Foreign Affairs and Trade, Simon Harris, stated that Ireland must prepare for the worst-case scenario in light of the potential pharmaceutical tariffs. Speaking after a meeting in Washington, D.C., with U.S. Commerce Secretary Howard Lutnick, Harris expressed cautious optimism but emphasised the need for readiness.
He added that he believes EU trade negotiator Maroš Šefčovič is capable of navigating the challenges ahead in ongoing discussions with the U.S.
Taoiseach Remains Hopeful
Irish Taoiseach Micheál Martin, speaking from Cork, acknowledged the growing uncertainty caused by the tariff threats. However, he struck a more hopeful tone, expressing his belief that constructive dialogue between the European Union and the United States could lead to a comprehensive trade agreement, particularly addressing pharmaceuticals and semiconductor technologies.
“These tariffs have introduced a high level of uncertainty, but we remain hopeful that reasoned negotiations will result in a mutually beneficial outcome,” Martin said.
Irish Samachar English News
{OR} Kindly click to follow the Irish Samachar News channel on WhatsApp